Biochemistry
-
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug Carmofur
This article has 21 authors:Reviewed by ScreenIT
-
Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity – opportunity for repurposed chemotherapy of COVID-19 infection
This article has 7 authors:Reviewed by ScreenIT
-
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
This article has 5 authors:Reviewed by ScreenIT
-
Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
This article has 4 authors:Reviewed by ScreenIT
-
Molecular Basis for ADP-ribose Binding to the Macro-X Domain of SARS-CoV-2 Nsp3
This article has 5 authors:Reviewed by ScreenIT
-
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
This article has 12 authors:Reviewed by ScreenIT
-
SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution
This article has 12 authors:Reviewed by ScreenIT
-
Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease
This article has 27 authors:Reviewed by ScreenIT
-
Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target
This article has 28 authors:Reviewed by ScreenIT
-
The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
This article has 1 author:Reviewed by ScreenIT